The expression of EMA, Ber-EP4, and calretinin showed significant differences between adenocarcinoma and the benign mesothelial cells (p < 0.001) but the expression of p63 showed no significant difference between adenocarcinoma and the benign mesothelial cells (p > 0.999) (Table 2). This evidence concerns the gene EPCAM and adenocarcinoma.